DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) - ACCELERON PHARMA INC ownership

ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 218 filers reported holding ACCELERON PHARMA INC in Q1 2020. The put-call ratio across all filers is 1.14 and the average weighting 0.3%.

Quarter-by-quarter ownership
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) ownership history of ACCELERON PHARMA INC
ValueSharesWeighting
Q3 2021$24,955,000
-9.4%
145,000
-33.9%
0.49%
-0.4%
Q2 2021$27,545,000
-7.5%
219,5000.0%0.49%
-21.9%
Q1 2021$29,766,000
-44.8%
219,500
-47.9%
0.63%
-41.3%
Q4 2020$53,942,000
+13.7%
421,6190.0%1.07%
-7.7%
Q3 2020$47,445,000
+18.1%
421,6190.0%1.16%
-1.3%
Q2 2020$40,168,000
+30.3%
421,619
+22.9%
1.17%
+19.6%
Q1 2020$30,825,000
-57.6%
343,000
-75.0%
0.98%
-57.8%
Q4 2019$72,618,000
+40.8%
1,369,625
+4.9%
2.32%
+10.2%
Q3 2019$51,567,000
-3.8%
1,305,1740.0%2.10%
+9.1%
Q2 2019$53,617,000
-8.3%
1,305,174
+4.0%
1.93%
-14.1%
Q1 2019$58,453,000
-3.2%
1,255,174
-9.5%
2.24%
-7.3%
Q4 2018$60,384,000
-5.6%
1,386,541
+24.1%
2.42%
+5.5%
Q3 2018$63,963,000
+17.0%
1,117,651
-0.8%
2.29%
+19.3%
Q2 2018$54,672,000
+127.4%
1,126,800
+83.2%
1.92%
+130.5%
Q1 2018$24,047,000
-7.9%
615,0000.0%0.83%
-18.9%
Q4 2017$26,101,000
+13.7%
615,0000.0%1.03%
-0.7%
Q3 2017$22,952,000
+146.0%
615,000
+74.0%
1.03%
+160.5%
Q1 2016$9,329,000
-10.4%
353,491
+65.6%
0.40%
-5.9%
Q4 2015$10,410,000213,4910.42%
Other shareholders
ACCELERON PHARMA INC shareholders Q1 2020
NameSharesValueWeighting ↓
Novo Holdings A/S 1,103,937$53,563,0005.39%
GREAT POINT PARTNERS LLC 758,000$36,778,0005.10%
Foresite Capital Management II, LLC 244,756$11,876,0004.18%
GREAT POINT PARTNERS LLC 552,300$26,798,0003.71%
Foresite Capital Management III, LLC 278,753$13,525,0002.91%
QVT Financial LP 190,977$9,266,0002.66%
Perceptive Advisors 1,528,205$74,149,0001.94%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 1,126,800$54,672,0001.92%
SECTORAL ASSET MANAGEMENT INC 306,626$14,877,0001.66%
Parametrica Management Ltd 5,645$274,0001.30%
View complete list of ACCELERON PHARMA INC shareholders